John Hamm - VP Chief Financial Officer at Cumberland Pharmaceuticals Inc

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	26K	$47.1K	$1.81	Mar 23, 2024	Direct
Options (right to buy)	12.5K	$21.4K	$1.71	Mar 25, 2024	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.